Related Experiment Videos

Adriamycin induces exocytosis in rat and beige mouse peritoneal mast cells: an ultrastructural, morphometric and

E Crivellato1, L Candussio, G Decorti

  • 1Department of Medical and Morphological Research, University of Udine, Italy. enrico.crivellato@kolbe.drmm.uniud.it

Journal of Submicroscopic Cytology and Pathology
|August 24, 1999
PubMed

Insights

Adriamycin (ADR) triggers non-cytotoxic histamine release and drug uptake in rat mast cells via sequential exocytosis, a process similar to compound 48/80. Beige mouse mast cells exhibit a slower exocytosis with distinct morphological features.

Area of Science:

  • Cell Biology
  • Pharmacology

Background:

  • Mast cells are key players in allergic responses and immune modulation.
  • Adriamycin (ADR) is an anticancer drug known to affect cellular processes.

Purpose of the Study:

  • To investigate the mechanism of exocytosis induced by ADR in rat and beige mouse peritoneal mast cells.
  • To characterize the morphological and biochemical aspects of ADR-induced histamine release and drug uptake.

Main Methods:

  • Transmission electron microscopy for ultrastructural analysis.
  • Spectrofluorimetry for quantifying histamine release and ADR uptake.
  • Fluorescence microscopy for visualizing ADR accumulation.

Main Results:

  • ADR induced rapid, sequential exocytosis in rat mast cells at 37°C, with massive histamine release and ADR uptake within 30 seconds.
  • At 22°C, rat mast cell exocytosis was slower, involving granule alteration and cavity formation.
  • Beige mouse mast cells showed a slower exocytosis (20 min at 37°C) with distinct cytoplasmic rigidity and less granule fusion.

Conclusions:

  • ADR-induced exocytosis in rat mast cells shares similarities with basic secretagogue-induced exocytosis.
  • Differences in exocytosis mechanisms were observed between rat and beige mouse mast cells, potentially due to variations in cytoplasmic structure.

Related Concept Videos